Skip to content
CIRI-IT
  • HOME-Eng
  • Organization
    • The Origins
    • The Scientific Committee
    • The Center’s Objectives
    • Future Perspectives
  • Research
    • Study on RSV epidemiology and impact: RESPIRA 50
    • RSV ComNet Project
    • EPSS Studies
    • ID.DRIVE
  • Publications
  • News_En
    • Nirsevimab: a new opportunity for RSV prevention in newborns
    • Sexually transmitted diseases
    • Prevention and control of Influenza in the 2024–2025 season
  • Contacts
    • Newsletter
  • NVPP 2023–2025
  • Toggle website search
Search this website
Menu Close
  • HOME-Eng
  • Organization
    • The Origins
    • The Scientific Committee
    • The Center’s Objectives
    • Future Perspectives
  • Research
    • Study on RSV epidemiology and impact: RESPIRA 50
    • RSV ComNet Project
    • EPSS Studies
    • ID.DRIVE
  • Publications
  • News_En
    • Nirsevimab: a new opportunity for RSV prevention in newborns
    • Sexually transmitted diseases
    • Prevention and control of Influenza in the 2024–2025 season
  • Contacts
    • Newsletter
  • NVPP 2023–2025
  • Toggle website search
Read more about the article 2030 Agenda for Sustainable Development

2030 Agenda for Sustainable Development

Continue Reading2030 Agenda for Sustainable Development
Read more about the article National Vaccination Prevention Plan 2023–2025

National Vaccination Prevention Plan 2023–2025

Il Piano Nazionale Prevenzione vaccinale (PNPV) 2023-2025 è stato approvato in Conferenza Stato-Regioni il 2 agosto 2023.  Questo è uno strumento per…

Continue ReadingNational Vaccination Prevention Plan 2023–2025
Read more about the article Measles: 3.266% increase in cases in Europe and Central Asia in one year

Measles: 3.266% increase in cases in Europe and Central Asia in one year

Continue ReadingMeasles: 3.266% increase in cases in Europe and Central Asia in one year
Read more about the article Two RSV vaccines approved – 2023

Two RSV vaccines approved – 2023

Continue ReadingTwo RSV vaccines approved – 2023
Older Posts →

Search

CM_EN

  • HOME-Eng
  • Organization
    • The Origins
    • The Scientific Committee
    • The Center’s Objectives
    • Future Perspectives
  • Research
    • Study on RSV epidemiology and impact: RESPIRA 50
    • RSV ComNet Project
    • EPSS Studies
    • ID.DRIVE
  • Publications
  • News_En
    • Nirsevimab: a new opportunity for RSV prevention in newborns
    • Sexually transmitted diseases
    • Prevention and control of Influenza in the 2024–2025 season
  • Contacts
    • Newsletter
  • NVPP 2023–2025

Restricted Area

  • Accesso
© Copyright 2023 - CIRI-IT InterUniversity Research Center on Influenza

SPECIALE COVID-19

Lorem ipsum dolor sit amet, consectetur adipiscing elit. In pulvinar erat ut venenatis maximus. Duis varius fermentum imperdiet. Morbi ipsum odio, ultricies non diam et, consectetur auctor lacus. Nunc a mi tellus. Nullam sit amet urna imperdiet, malesuada enim et, rutrum libero. Donec vel orci quis felis dapibus lobortis et at diam. Suspendisse at vehicula risus, maximus pretium dolor. Duis congue dolor nec ante dapibus, et venenatis libero finibus. Donec in mattis est. Morbi euismod, metus at lobortis rhoncus, lacus arcu malesuada lectus, sed pharetra magna diam ut purus. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Integer quis lorem vulputate, elementum lacus non, porta ipsum.